rs750451693
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_000096.4(CP):c.583G>A(p.Gly195Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,613,778 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000011 ( 0 hom. )
Consequence
CP
NM_000096.4 missense
NM_000096.4 missense
Scores
14
1
1
Clinical Significance
Conservation
PhyloP100: 7.38
Genes affected
CP (HGNC:2295): (ceruloplasmin) The protein encoded by this gene is a metalloprotein that binds most of the copper in plasma and is involved in the peroxidation of Fe(II)transferrin to Fe(III) transferrin. Mutations in this gene cause aceruloplasminemia, which results in iron accumulation and tissue damage, and is associated with diabetes and neurologic abnormalities. Two transcript variants, one protein-coding and the other not protein-coding, have been found for this gene. [provided by RefSeq, Feb 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.967
PP5
Variant 3-149210191-C-T is Pathogenic according to our data. Variant chr3-149210191-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 521552.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=2, Likely_pathogenic=2}.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CP | ENST00000264613.11 | c.583G>A | p.Gly195Arg | missense_variant | 3/19 | 1 | NM_000096.4 | ENSP00000264613.6 | ||
CP | ENST00000490639.5 | n.615G>A | non_coding_transcript_exon_variant | 3/17 | 1 | |||||
CP | ENST00000481169.5 | n.583G>A | non_coding_transcript_exon_variant | 3/18 | 2 | ENSP00000418773.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152048Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
152048
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251348Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135840
GnomAD3 exomes
AF:
AC:
4
AN:
251348
Hom.:
AF XY:
AC XY:
2
AN XY:
135840
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461730Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727166
GnomAD4 exome
AF:
AC:
16
AN:
1461730
Hom.:
Cov.:
31
AF XY:
AC XY:
6
AN XY:
727166
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152048Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74256
GnomAD4 genome
AF:
AC:
3
AN:
152048
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74256
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 31, 2017 | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 30, 2024 | Previously reported in a patient with aceruloplasminemia; however, it is not clear if this was seen in the homozygous or heterozygous state with a second variant, and no additional family history or clinical information was provided (PMID: 16775387); Published functional studies demonstrate a damaging effect through abnormal protein retention in the endoplasmic reticulum leading to decreased cell viability (PMID: 16775387); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also known as G176R using alternate nomenclature; This variant is associated with the following publications: (PMID: 34426522, 16775387) - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 20, 2024 | Variant summary: CP c.583G>A (p.Gly195Arg) results in a non-conservative amino acid change located in the N-terminal domain (IPR011707) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 251348 control chromosomes (gnomAD). c.583G>A (aka. G176R ) has been reported in the literature as a non-informative genotype (second allele not specified) in at-least one individual affected with features of aceruloplasminemia who has been subsequently cited by others (example, Kono_2006 cited in Vila-Cuenca_2020). These report(s) do not provide unequivocal conclusions about association of the variant with Neurodegeneration With Brain Iron Accumulation. Publications also reported experimental evidence evaluating an impact on protein function, and demonstrated that the G176R variant protein accumulated in the endoplasmic reticulum (ER), resulting increased ER stress response and lower cell viability (e.g. Kono_2006, Kono_2010, Thepsuwan_2023). The following publications have been ascertained in the context of this evaluation (PMID: 20655381, 16629161, 16775387, 32235485, 36595688). ClinVar contains an entry for this variant (Variation ID: 521552). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. - |
Deficiency of ferroxidase Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 26, 2021 | This sequence change replaces glycine with arginine at codon 195 of the CP protein (p.Gly195Arg). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and arginine. This variant is present in population databases (rs750451693, ExAC 0.001%). This missense change has been observed in individual(s) with aceruloplasminemia (PMID: 16629161). In at least one individual the data is consistent with the variant being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as G176R. ClinVar contains an entry for this variant (Variation ID: 521552). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects CP function (PMID: 16775387). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D
MetaSVM
Pathogenic
D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Vest4
MutPred
Loss of glycosylation at S191 (P = 0.096);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at